Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

from Listen to The Lancet Oncology · host The Lancet

Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.

Episode metadata supplied by the publisher feed · Published Sep 29, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

0:00 16:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 16 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on September 29, 2020.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!